The Global Blood Grouping Reagents market in 2023 showcased China's dominance with a substantial market share, followed by the United Kingdom and Spain. While most countries exhibited modest growth, Brazil, Greece, Australia, Portugal, Belgium, Croatia, Denmark, Slovenia, and Lithuania reported declines, with Australia and Portugal experiencing the most significant decreases year-on-year. The past five years show that despite some volatility, markets like Thailand showed potential for robust growth, reflected in its highest annual growth rate.
Looking ahead, the demand for blood grouping reagents is expected to be driven by advancements in healthcare infrastructure, increased prevalence of blood-related disorders, and growing awareness of blood testing importance. Emerging markets like Thailand may offer new growth opportunities, while established ones like China will continue to maintain significant market shares.
Top countries in Blood Grouping Reagents Market Size Value Share by Country (US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 42.05 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 13.21 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 12.35 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 11.34 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 4.2 | 2023 | -3.18% | -3.78% | View data |
| 6 | 6 Poland | 2.66 | 2023 | +0.22% | +0.62% | View data |
| 7 | 7 Thailand | 2.46 | 2023 | +5.58% | +6.99% | View data |
| 8 | 8 Greece | 1.69 | 2023 | -1.36% | -2.09% | View data |
| 9 | 9 Australia | 1.21 | 2023 | -9.35% | -7.54% | View data |
| 10 | 10 Hungary | 1.01 | 2023 | +0.8% | -2.77% | View data |
